David Emerson Jorden, CEO/CFO at Nuo Therapeutics, Inc. (AURX), sold 112,500 shares at $1.50 ($169K) on 2022-11-09, disclosed to the SEC on 2022-11-14.
Open-market sale of $169k AURX by CEO/CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 5,000 | $8K | 4.4% |
| 2 | $1.50 | 7,000 | $11K | 6.2% |
| 3 | $1.50 | 10,000 | $15K | 8.9% |
| 4 | $1.50 | 13,500 | $20K | 12.0% |
| 5 | $1.50 | 20,000 | $30K | 17.8% |
| 6 | $1.50 | 27,000 |
| $41K |
| 24.0% |
| 7 | $1.50 | 30,000 | $45K | 26.7% |
| Total | $1.50 avg | 112,500 | $169K | 100% |
| Filing → |
| PLXP | BUY | 2017-06-16 | $450K | — | Filing → |
| PrivateNuo Therapeutics, Inc. | BUY | 2016-07-29 | $138K | — | Filing → |
| CMXI | BUY | 2013-05-21 | $40K | — | Filing → |